Iron chelators for thalassaemia

被引:125
作者
Hershko, C
Konijn, AM
Link, G
机构
[1] Shaare Zedek Med Ctr, Dept Med, IL-91031 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Human Nutr & Metab, Jerusalem, Israel
关键词
iron chelators; iron toxicity; desferroxamine; deferiprone; thalassaemia;
D O I
10.1046/j.1365-2141.1998.00726.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:399 / 406
页数:8
相关论文
共 78 条
[71]  
ROTHMAN RJ, 1992, MOL PHARMACOL, V42, P703
[72]  
SCHNEBLI HP, 1997, THAL 6 INT C THAL HA
[73]   Liver iron and fibrosis during long-term treatment with deferiprone in Swiss thalassaemic patients [J].
Töndury, P ;
Zimmermann, A ;
Nielsen, P ;
Hirt, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (03) :413-415
[74]  
TONDURY P, 1990, BRIT J HAEMATOL, V76, P550
[75]  
TONDURY P, 1997, 6 INT C THAL HAEM ST
[76]  
TRICTA F, 1997, 8 INT C OR CHEL TEAT, P44
[77]  
WINCHELL HS, 1996, Patent No. 10785
[78]  
ZIEL R, 1993, 5 INT C THAL HAEM NI